Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 8/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.42 |
| ▸ | TACR2 | P21452 | 7/20 | 0.41 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7494730 | 0.94 | HRH1 (0.42) | HRH1KCNH2TACR2SSTR5CHRM1 | |
| SCHEMBL7493089 | 0.93 | SSTR5 (0.47) | HRH1KCNH2TACR2SSTR5CHRM1 | |
| SCHEMBL7499627 | 0.93 | HRH1 (0.47) | HRH1KCNH2TACR2SSTR5 | |
| SCHEMBL7495286 | 0.93 | KCNH2 (0.51) | HRH1KCNH2TACR2SSTR5CHRM1 | |
| SCHEMBL7492400 | 0.93 | HRH1 (0.44) | HRH1KCNH2TACR2SSTR5CHRM1 | |
| SCHEMBL7502500 | 0.92 | HRH1 (0.45) | HRH1KCNH2TACR2SSTR5 | |
| SCHEMBL7496857 | 0.92 | KCNH2 (0.43) | HRH1KCNH2TACR2SSTR5CHRM1 | |
| SCHEMBL7495454 | 0.91 | HRH1 (0.47) | HRH1KCNH2TACR2 | |
| SCHEMBL7493728 | 0.91 | SSTR5 (0.45) | HRH1KCNH2TACR2SSTR5CHRM1 | |
| SCHEMBL7495098 | 0.91 | KCNH2 (0.48) | HRH1KCNH2TACR2SSTR5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888336-B1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL-AMINO)P IPERIDIN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | AVENTIS PHARMA INC (US) | 2002-08-07 | — | — | EP | disclosed |
| US-5922737-A | Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases | HOECHST MARION ROUSSEL, INC. (US) | 1999-07-13 | — | — | US | disclosed |
| EP-0888336-A1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL-AMINO)P IPERIDIN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997030989-A1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL-AMINO)PIPERIDIN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | HOECHST MARION ROUSSEL, INC. (US) | 1997-08-28 | — | — | WO | disclosed |